These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24867965)

  • 1. New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharides.
    Sautrey G; Zimmermann L; Deleu M; Delbar A; Souza Machado L; Jeannot K; Van Bambeke F; Buyck JM; Decout JL; Mingeot-Leclercq MP
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4420-30. PubMed ID: 24867965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interest of Homodialkyl Neamine Derivatives against Resistant
    Swain J; Dezanet C; Chalhoub H; Auquière M; Kempf J; Décout JL; Mingeot-Leclercq MP
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pseudomonas aeruginosa membranes: a target for a new amphiphilic aminoglycoside derivative?
    Ouberai M; El Garch F; Bussiere A; Riou M; Alsteens D; Lins L; Baussanne I; Dufrêne YF; Brasseur R; Decout JL; Mingeot-Leclercq MP
    Biochim Biophys Acta; 2011 Jun; 1808(6):1716-27. PubMed ID: 21291859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of amphiphilic neamine derivatives: Understanding the mechanism of action on Gram-positive bacteria.
    Swain J; El Khoury M; Flament A; Dezanet C; Briée F; Van Der Smissen P; Décout JL; Mingeot-Leclercq MP
    Biochim Biophys Acta Biomembr; 2019 Oct; 1861(10):182998. PubMed ID: 31153908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad-spectrum antibacterial amphiphilic aminoglycosides: A new focus on the structure of the lipophilic groups extends the series of active dialkyl neamines.
    Zimmermann L; Kempf J; Briée F; Swain J; Mingeot-Leclercq MP; Décout JL
    Eur J Med Chem; 2018 Sep; 157():1512-1525. PubMed ID: 30282323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
    Zimmermann L; Bussière A; Ouberai M; Baussanne I; Jolivalt C; Mingeot-Leclercq MP; Décout JL
    J Med Chem; 2013 Oct; 56(19):7691-705. PubMed ID: 24083676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues.
    Zimmermann L; Das I; Désiré J; Sautrey G; Barros R S V; El Khoury M; Mingeot-Leclercq MP; Décout JL
    J Med Chem; 2016 Oct; 59(20):9350-9369. PubMed ID: 27690420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
    Baussanne I; Bussière A; Halder S; Ganem-Elbaz C; Ouberai M; Riou M; Paris JM; Ennifar E; Mingeot-Leclercq MP; Décout JL
    J Med Chem; 2010 Jan; 53(1):119-27. PubMed ID: 20000576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane.
    Sabnis A; Hagart KL; Klöckner A; Becce M; Evans LE; Furniss RCD; Mavridou DA; Murphy R; Stevens MM; Davies JC; Larrouy-Maumus GJ; Clarke TB; Edwards AM
    Elife; 2021 Apr; 10():. PubMed ID: 33821795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphiphilic Aminoglycosides as Medicinal Agents.
    Dezanet C; Kempf J; Mingeot-Leclercq MP; Décout JL
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial activity of novel neamine derivatives.
    Minowa N; Akiyama Y; Hiraiwa Y; Maebashi K; Usui T; Ikeda D
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6351-4. PubMed ID: 16997557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New amphiphilic neamine conjugates bearing a metal binding motif active against MDR E. aerogenes Gram-negative bacteria.
    Allam A; Maigre L; Alves de Sousa R; Dumont E; Vergalli J; Pagès JM; Artaud I
    Eur J Med Chem; 2017 Feb; 127():748-756. PubMed ID: 27823890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salt-resistant short antimicrobial peptides.
    Mohanram H; Bhattacharjya S
    Biopolymers; 2016 May; 106(3):345-56. PubMed ID: 26849911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of large amounts of lipopolysaccharides from Pseudomonas aeruginosa cells reduces their susceptibility to colistin.
    Yokota SI; Hakamada H; Yamamoto S; Sato T; Shiraishi T; Shinagawa M; Takahashi S
    Int J Antimicrob Agents; 2018 Jun; 51(6):888-896. PubMed ID: 29432867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cardiolipin on the antimicrobial activity of a new amphiphilic aminoglycoside derivative on Pseudomonas aeruginosa.
    Swain J; El Khoury M; Kempf J; Briée F; Van Der Smissen P; Décout JL; Mingeot-Leclercq MP
    PLoS One; 2018; 13(8):e0201752. PubMed ID: 30125281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane.
    Imamura Y; Higashiyama Y; Tomono K; Izumikawa K; Yanagihara K; Ohno H; Miyazaki Y; Hirakata Y; Mizuta Y; Kadota J; Iglewski BH; Kohno S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1377-80. PubMed ID: 15793115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of chensinin-1b, a peptide with a random coil conformation, against multiple-drug-resistant Pseudomonas aeruginosa.
    Shang D; Meng X; Zhang D; Kou Z
    Biochem Pharmacol; 2017 Nov; 143():65-78. PubMed ID: 28756209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration.
    Gill MM; Rao JU; Kaleem F; Hassan A; Khalid A; Anjum R
    Pak J Pharm Sci; 2013 Jan; 26(1):7-10. PubMed ID: 23261721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.
    Jiao GS; Simo O; Nagata M; O'Malley S; Hemscheidt T; Cregar L; Millis SZ; Goldman ME; Tang C
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5183-9. PubMed ID: 16870442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance.
    Moore RA; Hancock RE
    Antimicrob Agents Chemother; 1986 Dec; 30(6):923-6. PubMed ID: 3028253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.